|
MCM3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.797680E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.718560E-03 |
| Normal-vs-Stage2 |
1.79388000000058E-05 |
| Normal-vs-Stage3 |
1.94159999999943E-05 |
| Normal-vs-Stage4 |
1.201370E-03 |
| Stage1-vs-Stage2 |
1.419530E-02 |
| Stage1-vs-Stage3 |
8.097300E-03 |
| Stage1-vs-Stage4 |
4.873400E-01 |
| Stage2-vs-Stage3 |
6.523000E-01 |
| Stage2-vs-Stage4 |
1.140580E-01 |
| Stage3-vs-Stage4 |
1.564150E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.002530E-04 |
| Normal-vs-AfricanAmerican |
4.974400E-02 |
| Normal-vs-Asian |
2.529400E-01 |
| Caucasian-vs-AfricanAmerican |
1.318210E-01 |
| Caucasian-vs-Asian |
2.193600E-01 |
| AfricanAmerican-vs-Asian |
7.564400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.85570000000346E-05 |
| Normal-vs-Female |
1.521720E-03 |
| Male-vs-Female |
8.578100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.320300E-02 |
| Normal-vs-Age(41-60Yrs) |
9.039300E-04 |
| Normal-vs-Age(61-80Yrs) |
1.009000E-04 |
| Normal-vs-Age(81-100Yrs) |
1.56550999999006E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.086600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.584800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.854200E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.674050E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.068000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.150100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.005000E-01 |
| Normal-vs-Grade 2 |
1.321140E-03 |
| Normal-vs-Grade 3 |
2.49769999999261E-05 |
| Normal-vs-Grade 4 |
4.767500E-04 |
| Grade 1-vs-Grade 2 |
4.053800E-02 |
| Grade 1-vs-Grade 3 |
4.537600E-03 |
| Grade 1-vs-Grade 4 |
2.947900E-02 |
| Grade 2-vs-Grade 3 |
1.720160E-02 |
| Grade 2-vs-Grade 4 |
2.482000E-01 |
| Grade 3-vs-Grade 4 |
6.089400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.766700E-04 |
| Normal-vs-ccB subtype |
2.756200E-04 |
| ccA subtype-vs-ccB subtype |
7.160000E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.198680E-04 |
| Normal-vs-N1 |
3.517000E-01 |
| N0-vs-N1 |
1.109580E-01 |
|
|
